224 related articles for article (PubMed ID: 9006785)
21. Chronopharmacokinetics of theophylline administered as a controlled-release tablet.
Thielemann AM; Manquez N; Pinilla E; Gai MN; Romero P; Arancibia A; Chavez H
Int J Clin Pharmacol Ther; 1996 Mar; 34(3):130-3. PubMed ID: 8705090
[TBL] [Abstract][Full Text] [Related]
22. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
24. 'Dose dumping' and sustained-release theophylline.
Welch JS
Am Fam Physician; 1995 Oct; 52(5):1278, 1284. PubMed ID: 7572551
[No Abstract] [Full Text] [Related]
25. Postprandial release of cholecystokinin and pancreatic polypeptide in health and in gallstone disease: relationships with gallbladder contraction.
Glasbrenner B; Domínguez-Muñoz JE; Nelson DK; Pieramico O; Holzwarth C; Riepl RL; Malfertheiner P
Am J Gastroenterol; 1994 Mar; 89(3):404-10. PubMed ID: 8122654
[TBL] [Abstract][Full Text] [Related]
26. Acute intraduodenal bile salt depletion leads to strong gallbladder contraction, altered antroduodenal motility and high plasma motilin levels in humans.
Portincasa P; Peeters TL; van Berge-Henegouwen GP; van Solinge WW; Palasciano G; van Erpecum KJ
Neurogastroenterol Motil; 2000 Oct; 12(5):421-30. PubMed ID: 11012942
[TBL] [Abstract][Full Text] [Related]
27. [Requirements for product quality of theophylline sustained-release preparations].
Fuchs WS; Hens C; von Nieciecki A
Arzneimittelforschung; 1998 May; 48(5A):556-61. PubMed ID: 9676344
[TBL] [Abstract][Full Text] [Related]
28. Misoprostol induces gallbladder contraction during fasting, but does not influence postprandial emptying: an ultrasound study in healthy subjects.
Acalovschi M; Dumitrascu DL; Suteu T; Veres A; Albu S; Badea RI
Acta Gastroenterol Belg; 2002; 65(4):191-5. PubMed ID: 12619424
[TBL] [Abstract][Full Text] [Related]
29. Effect of food on bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms: Part I.
Ohmori N; Inotsume N; Matsukura M; Higashi A; Iwaoku R; Tobino Y; Nakano M; Matsuda I
Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):148-52. PubMed ID: 3699941
[TBL] [Abstract][Full Text] [Related]
30. Effects of intravenous infusion of amino acids on cholecystokinin release and gallbladder contraction in humans.
Shirohara H; Tabaru A; Otsuki M
J Gastroenterol; 1996 Aug; 31(4):572-7. PubMed ID: 8844480
[TBL] [Abstract][Full Text] [Related]
31. Effect of pretreatment with ranitidine on the pharmacokinetics and gastrointestinal transit of a sustained release theophylline preparation.
Wilson CG; Washington N; Greaves JL; Blackshaw PE; Perkins AC; Barkworth MF; Rehm KD
Arzneimittelforschung; 1991 Nov; 41(11):1154-9. PubMed ID: 1810260
[TBL] [Abstract][Full Text] [Related]
32. Effect of grapefruit juice on the pharmacokinetics of theophylline in healthy male volunteers.
Gupta MC; Garg SK; Badyal D; Malhotra S; Bhargava VK
Methods Find Exp Clin Pharmacol; 1999 Dec; 21(10):679-82. PubMed ID: 10702965
[TBL] [Abstract][Full Text] [Related]
33. Effect of Albiglutide on Cholecystokinin-Induced Gallbladder Emptying in Healthy Individuals: A Randomized Crossover Study.
Shaddinger BC; Young MA; Billiard J; Collins DA; Hussaini A; Nino A
J Clin Pharmacol; 2017 Oct; 57(10):1322-1329. PubMed ID: 28543352
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of the theophylline pharmacokinetics of sustained-release theophylline (Theodur) dry syrup in children].
Okuma M; Iikura Y
Arerugi; 1999 Jun; 48(6):589-96. PubMed ID: 10423899
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
González MA; Kisicki J; Straughn AB
Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
[TBL] [Abstract][Full Text] [Related]
36. Intraduodenal conjugated bile salts exert negative feedback control on gall bladder emptying in the fasting state without affecting cholecystokinin release or antroduodenal motility.
van Ooteghem NA; Moschetta A; Rehfeld JF; Samsom M; van Erpecum KJ; van Berge-Henegouwen GP
Gut; 2002 May; 50(5):669-74. PubMed ID: 11950814
[TBL] [Abstract][Full Text] [Related]
37. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of gallbladder emptying decreases cholesterol saturation in bile in the Richardson ground squirrel.
Pauletzki JG; Xu QW; Shaffer EA
Hepatology; 1995 Jul; 22(1):325-31. PubMed ID: 7601426
[TBL] [Abstract][Full Text] [Related]
39. Study on the effect of food on the absorption of theophylline.
Su YM; Cheng TP; Wen CY
J Chin Med Assoc; 2003 Dec; 66(12):715-21. PubMed ID: 15015820
[TBL] [Abstract][Full Text] [Related]
40. HPLC analysis of theophylline: bioequivalence study of two sustained-release formulations at steady state.
Mazzei M; Sottofattori E; Balbi A; Bottino GB
Farmaco; 1992 May; 47(5 Suppl):769-77. PubMed ID: 1524625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
